Video

Dr. Giri Discusses Testing for Inherited Prostate Cancer

Author(s):

Veda Giri, MD, associate professor, Thomas Jefferson University Hospital, discusses testing for inherited prostate cancer.

Veda Giri, MD, associate professor, Thomas Jefferson University Hospital, discusses testing for inherited prostate cancer.

There are few scenarios in which men should consider getting tested for inherited prostate cancer, says Giri. For a man who has had metastatic disease and is progressing after going through the standard lines of therapy, genetics can inform additional options for treatment or clinical trials. There are increasing FDA indications for PARP inhibitors and checkpoint inhibitors for patients with mismatch repair-deficient cancers, says Giri.

Another group of men who may want to consider genetic testing are those who have a family history of cancer. This is not limited to prostate cancer, says Giri, but men who have a family history of breast, ovarian, pancreatic or colon cancer, as these malignancies can be linked to inherited risk for prostate cancer.

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Elias Jabbour, MD
Daniel DeAngelo, MD, PhD
Douglas W. Sborov, MD, MS